T2 Biosystems (TTOO) Reports Q4 Revenues Below Estimates; Provides Q1 & FY19 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq set for higher open as oil prices extend declines, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Canaccord Defends T2 Biosystems (TTOO), Says Refuting the Short Story, Buy on Weakness
March 5, 2019 1:36 PM ESTCanaccord analyst Mark Massaro is defending T2 Biosystems (NASDAQ: TTOO) by saying buy on weakness. Analyst comments: "Shares of T2 Biosystems are down 15% on a short report that appears on Seeking Alpha. As we previewed this morning, T2 is set to... More
White Diamond Research negatived on T2 Biosystems (TTOO), sets $1.50 price target
March 5, 2019 10:03 AM ESTWhite Diamond Research negatived on T2 Biosystems (NASDAQ: TTOO), sets $1.50 price target (LINK)



